Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Trevena Company

TRVN
US89532E1091
A1XDSL

Price

4.61
Today +/-
+0.55
Today %
+14.12 %
P

Trevena stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Trevena stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Trevena stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Trevena stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Trevena's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Trevena Stock Price History

DateTrevena Price
10/4/20244.61 undefined
10/3/20244.00 undefined
10/2/20243.75 undefined
10/1/20243.94 undefined
9/30/20243.74 undefined
9/27/20243.98 undefined
9/26/20243.89 undefined
9/25/20243.90 undefined
9/24/20244.01 undefined
9/23/20243.70 undefined
9/20/20244.01 undefined
9/19/20244.70 undefined
9/18/20244.89 undefined
9/17/20244.95 undefined
9/16/20244.45 undefined
9/13/20245.95 undefined
9/12/20246.70 undefined
9/11/20247.49 undefined
9/10/20247.84 undefined
9/9/20245.10 undefined

Trevena Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Trevena, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Trevena from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Trevena’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Trevena. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Trevena’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Trevena’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Trevena’s growth potential.

Trevena Revenue, EBIT and net profit per share

DateTrevena RevenueTrevena EBITTrevena Net Income
2028e806.95 M undefined666.1 M undefined14.83 M undefined
2027e294.84 M undefined208.72 M undefined5.48 M undefined
2026e0 undefined-34.76 M undefined-21.46 M undefined
2025e9.13 M undefined-27.12 M undefined-17.21 M undefined
2024e163,200 undefined-33.41 M undefined-27.04 M undefined
20233.13 M undefined-35.29 M undefined-40.29 M undefined
2022-420,000 undefined-56.38 M undefined-53.67 M undefined
2021570,000 undefined-51.93 M undefined-51.59 M undefined
20203.07 M undefined-29.49 M undefined-29.37 M undefined
201930,000 undefined-26.47 M undefined-24.87 M undefined
20185.73 M undefined-29.07 M undefined-30.78 M undefined
20170 undefined-68.62 M undefined-71.87 M undefined
20163.75 M undefined-102.28 M undefined-102.99 M undefined
20156.25 M undefined-50.62 M undefined-50.53 M undefined
20140 undefined-49.95 M undefined-49.73 M undefined
2013130,000 undefined-23.35 M undefined-23.59 M undefined
2012810,000 undefined-15.61 M undefined-15.95 M undefined
20112.42 M undefined-15.75 M undefined-15.88 M undefined

Trevena Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
2000630503003090294806
------50.00-----------174.15
---------66.67--33.33-----
00000000020-3100000
-15-15-23-49-50-102-68-29-26-29-51-56-35-33-27-34208666
-750.00----833.33-3,400.00--580.00--966.67---1,166.67--300.00-70.7582.63
-15-15-23-49-50-102-71-30-24-29-51-53-40-27-17-21514
--53.33113.042.04104.00-30.39-57.75-20.0020.8375.863.92-24.53-32.50-37.0423.53-123.81180.00
0.890.891.030.991.752.12.382.943.675.16.537.070.5100000
------------------
Details

Keystats

ⓘ

Revenue and Growth

The Trevena Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Trevena is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2011201220132014201520162017201820192020202120222023
                         
17.16.738106.9172.6110.666.161.535.8109.466.938.332.98
000000000100000
0000000009000
00000000002.40.90
0.40.340.71.91.81.40.61.70.61.41.82.23
17.5742107.6174.5112.467.562.137.5119.170.74135.21
1.70.90.30.60.71.13.83.48.27.46.55.74.86
0000000000000
0000000000000
0000000000000
0000000000000
0.30.20.10.10.11.21.41.31.31.32.920.54
21.10.40.70.82.35.24.79.58.79.47.75.4
19.58.142.4108.3175.3114.772.766.847127.880.148.740.61
                         
58.659120.600.10.10.10.10.10.20.200.02
0.200.7231.2325.8364.1392.1429.7443.1546.4558.6563.4580.39
-43.4-59-82.3-132-182.5-285.6-357.5-388.3-413.1-442.5-494.1-547.8-588.06
0000-0.200000000
0000000000000
15.403999.2143.278.634.741.530.1104.164.715.6-7.66
0.60.50.54.36.78.71.41.411.74.52.42.3
0.70.80.91.62.62.74.33.334.53.84.44.74
0.80.61.314.25.50.10.2010.40.920.5
0000000000000
0.22.1000512.412.650000.01
2.342.76.913.521.918.217.5916.69.28.87.55
0.32.801.718.213.315.84.800013.430.82
0000000000000
1.51.40.70.40.50.74.12.97.87.16.310.99.89
1.84.20.72.118.71419.97.77.87.16.324.340.71
4.18.23.4932.235.938.125.216.823.715.533.148.26
19.58.242.4108.2175.4114.572.866.746.9127.880.248.740.6
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Trevena provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Trevena's financial health and stability.

Assets

Trevena's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Trevena must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Trevena after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Trevena's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201120122013201420152016201720182019202020212022
-15-15-23-49-50-102-71-30-24-29-51-53
000000000000
000000000000
10-2753-70-23-31
000247753340
000001,0001,0001,0000000
000000000000
-13-14-24-39-40-91-71-25-23-21-50-51
000000-300000
000-71-5637322125300
000-70-5638362125300
000000000000
04-411609-12-12-5013
17060107913221331010189
16455109107323020-295723
----------1.00--
000000000000
3-1031-110-21-716077-42-27
-13.38-14.83-24.38-40.22-40.45-92.16-74.76-25.55-23.67-21.42-50.22-51.51
000000000000

Trevena stock margins

The Trevena margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Trevena. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Trevena.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Trevena's sales revenue. A higher gross margin percentage indicates that the Trevena retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Trevena's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Trevena's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Trevena's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Trevena. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Trevena's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Trevena Margin History

Trevena Gross marginTrevena Profit marginTrevena EBIT marginTrevena Profit margin
2028e46.56 %82.55 %1.84 %
2027e46.56 %70.79 %1.86 %
2026e46.56 %0 %0 %
2025e46.56 %-297.07 %-188.52 %
2024e46.56 %-20,470.63 %-16,568.36 %
202346.56 %-1,129.22 %-1,289.25 %
2022819.05 %13,423.81 %12,778.57 %
2021-68.42 %-9,110.53 %-9,050.88 %
202094.14 %-960.59 %-956.68 %
201946.56 %-88,233.33 %-82,900.01 %
201846.56 %-507.33 %-537.17 %
201746.56 %0 %0 %
201646.56 %-2,727.47 %-2,746.4 %
201546.56 %-809.92 %-808.48 %
201446.56 %0 %0 %
201346.56 %-17,961.54 %-18,146.16 %
201246.56 %-1,927.16 %-1,969.14 %
201146.56 %-650.83 %-656.2 %

Trevena Stock Sales Revenue, EBIT, Earnings per Share

The Trevena earnings per share therefore indicates how much revenue Trevena has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Trevena earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Trevena's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Trevena’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Trevena's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Trevena Revenue, EBIT and net profit per share

DateTrevena Sales per ShareTrevena EBIT per shareTrevena Earnings per Share
2028e949.35 undefined0 undefined17.45 undefined
2027e346.87 undefined0 undefined6.45 undefined
2026e0 undefined0 undefined-25.25 undefined
2025e10.74 undefined0 undefined-20.25 undefined
2024e0.19 undefined0 undefined-31.81 undefined
20236.13 undefined-69.27 undefined-79.09 undefined
2022-0.06 undefined-7.97 undefined-7.59 undefined
20210.09 undefined-7.95 undefined-7.9 undefined
20200.6 undefined-5.78 undefined-5.76 undefined
20190.01 undefined-7.21 undefined-6.78 undefined
20181.95 undefined-9.89 undefined-10.47 undefined
20170 undefined-28.83 undefined-30.2 undefined
20161.79 undefined-48.7 undefined-49.04 undefined
20153.57 undefined-28.93 undefined-28.87 undefined
20140 undefined-50.45 undefined-50.23 undefined
20130.13 undefined-22.67 undefined-22.9 undefined
20120.91 undefined-17.54 undefined-17.92 undefined
20112.72 undefined-17.7 undefined-17.84 undefined

Trevena business model

Trevena Inc is an international company specializing in drug development. It was founded in 2007 and is headquartered in Pennsylvania, USA. The history of Trevena begins with the discovery of G-protein coupled receptors (GPCRs), a group of proteins responsible for various biological processes in the body. The founders of Trevena recognized that blocking these receptors could contribute to pain relief and other diseases. With this knowledge, Trevena embarked on comprehensive research and development to develop new drugs. Trevena's business model is based on the development of drugs based on GPCR blockers. The company aims to specifically target diseases for which there is currently no satisfactory therapy. In close collaboration with leading scientists and doctors worldwide, Trevena's researchers and developers are working on the development of innovative drugs for a wide range of diseases. Trevena is divided into different divisions that focus on the development of drugs for different disease areas. These include pain therapy, cardiovascular diseases, and respiratory diseases. One of Trevena's most well-known products is their pain therapeutic Olinvyk (Oliceridine), which is approved for use in patients with moderate to severe pain. The drug is a GPCR blocker that works faster than other painkillers and has minimal side effects. Olinvyk is used in postoperative pain therapy and has the potential to reduce the use of opioids. Another promising drug from Trevena is TRV027, which was developed to treat cardiovascular diseases. The drug aims to reduce the effects of heart attacks and other cardiovascular events and has shown promising results in clinical studies. Trevena is constantly striving to intensify its research and development efforts and expand its product range. The company works closely with regulatory authorities worldwide to ensure the safety and efficacy of its drugs and achieve fast market approval. Overall, the company has made significant progress in recent years and has already brought several drugs to market that have the potential to significantly improve healthcare. The future of Trevena looks promising and holds hope for further innovative drugs. Trevena is one of the most popular companies on Eulerpool.com.

Trevena Revenue by Segment

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Trevena Revenue by Segment

Segmente2021
Product revenue498,000 USD
License revenue100,000 USD

Trevena SWOT Analysis

Strengths

Trevena Inc has a strong portfolio of innovative pharmaceutical products.

The company has a talented team of researchers and scientists.

Trevena Inc has a solid financial position with enough funds for research and development.

Weaknesses

Trevena Inc faces intense competition in the pharmaceutical industry.

The company is still dependent on a limited number of products for revenue generation.

Trevena Inc lacks a global presence and has limited market reach.

Opportunities

The growing demand for innovative pharmaceutical solutions presents a significant opportunity for Trevena Inc.

Expanding into international markets can provide new avenues for growth and revenue.

Increasing partnerships and collaborations can enhance research capabilities and market penetration.

Threats

The pharmaceutical industry is highly regulated, which can pose challenges for Trevena Inc.

Rapid advancements in technology may render Trevena Inc's products obsolete.

The company faces the risk of patent expirations and generic competition.

Trevena Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Trevena historical P/E ratio, EBIT multiple, and P/S ratio

Trevena shares outstanding

The number of shares was Trevena in 2023 — This indicates how many shares 509,400 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Trevena earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Trevena's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Trevena’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Trevena's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Trevena stock splits

In Trevena's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Trevena.

Trevena latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-10.33 -5.75  (44.32 %)2024 Q2
3/31/2024-11.99 -9  (24.91 %)2024 Q1
12/31/2023-0.39 -1.06  (-174.54 %)2023 Q4
9/30/2023-0.15 -0.57  (-275 %)2023 Q3
6/30/2023-1.07 -0.69  (35.69 %)2023 Q2
3/31/2023-1 -0.81  (19.24 %)2023 Q1
12/31/2022-1.79 -0.73  (59.1 %)2022 Q4
9/30/2022-2.17 -2.25  (-3.81 %)2022 Q3
6/30/2022-2.61 -2.25  (13.92 %)2022 Q2
3/31/2022-2.23 -2.5  (-12.04 %)2022 Q1
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the Trevena stock

Eulerpool World ESG Rating (EESG©)

62/ 100

🌱 Environment

69

👫 Social

48

🏛️ Governance

68

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Trevena shareholders

%
Name
Stocks
Change
Date
93.84871 % Armistice Capital LLC797,714797,71412/31/2023
8.51235 % The Vanguard Group, Inc.72,3551,87912/31/2023
7.94882 % Citadel Advisors LLC67,56567,56512/31/2023
4.57729 % Shin (Barry)38,907-204,2492/9/2024
4.31765 % Demitrack (Mark A)36,700-204,3732/9/2024
3.88235 % CAPTRUST Financial Advisors33,000012/31/2023
2.92518 % State Street Global Advisors (US)24,864012/31/2023
2.56753 % Fidelity Management & Research Company LLC21,824012/31/2023
17.82965 % Renaissance Technologies LLC151,552-25,90012/31/2023
17.73494 % Yoder (Robert T.)150,747112,46512/14/2023
1
2
3
4
5
...
10

Trevena Executives and Management Board

Ms. Carrie Bourdow60
Trevena Chairman of the Board, President, Chief Executive Officer (since 2015)
Compensation 1 M
Dr. Mark Demitrack65
Trevena Senior Vice President, Chief Medical Officer
Compensation 690,316
Mr. Robert Yoder57
Trevena Senior Vice President, Chief Business Officer and Head - Commercial Operations
Compensation 689,161
Mr. Barry Shin51
Trevena Chief Financial Officer, Chief Operating Officer, Executive Vice President
Compensation 670,025
Mr. Jake Nunn52
Trevena Independent Director
Compensation 98,429
1
2
3

Trevena Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Pfizer Stock
Pfizer
SupplierCustomer0,250,59-0,080,41-0,78-0,86
Syneos Health A Stock
Syneos Health A
SupplierCustomer0,050,400,840,920,38-0,60
Jiangsu Nhwa Pharm A Stock
Jiangsu Nhwa Pharm A
SupplierCustomer-0,16-0,540,200,750,460,68
1

Most common questions regarding Trevena

What values and corporate philosophy does Trevena represent?

Trevena Inc represents core values such as innovation, scientific excellence, and commitment to improving patient outcomes. With a strong corporate philosophy, the company aims to transform patient care by developing and delivering innovative therapies. Trevena Inc focuses on creating value for patients, healthcare providers, and shareholders by developing cutting-edge medicines that address unmet medical needs. By harnessing their expertise in G protein-coupled receptor (GPCR) biology, the company strives to develop differentiated drugs that provide superior therapeutic benefits. Trevena Inc's dedication to research and development, coupled with their patient-centric approach, positions them as a leader in the pharmaceutical industry.

In which countries and regions is Trevena primarily present?

Trevena Inc is primarily present in the United States.

What significant milestones has the company Trevena achieved?

Trevena Inc has achieved several significant milestones in its history. The company successfully received U.S. FDA approval for OLINVYK™ (oliceridine) injection, its first commercial product, in August 2020. This milestone marked a major accomplishment for Trevena Inc in providing a new treatment option for moderate to severe acute pain. Additionally, Trevena Inc has successfully advanced its pipeline of novel therapies, including TRV250 for acute migraine and TRV734 for neurogenic itch. These achievements highlight the company's commitment to developing innovative solutions and enhancing patient care in various therapeutic areas.

What is the history and background of the company Trevena?

Trevena Inc is a pharmaceutical company with a rich history and background. Founded in 2007, the company is headquartered in Pennsylvania, USA. Trevena Inc focuses on developing innovative therapies for patients suffering from central nervous system disorders. The company has made significant advancements in the field of biotechnology, particularly in their development of G protein-coupled receptor (GPCR) targeted medicines. Trevena Inc has received numerous accolades and recognition for its commitment to scientific research and dedication to improving patient outcomes. With a strong team of experts and a robust portfolio of drug candidates, Trevena Inc continues to strive towards providing breakthrough treatments for patients worldwide.

Who are the main competitors of Trevena in the market?

The main competitors of Trevena Inc in the market include pharmaceutical companies such as Pfizer, Novartis, and Johnson & Johnson.

In which industries is Trevena primarily active?

Trevena Inc is primarily active in the pharmaceutical industry.

What is the business model of Trevena?

The business model of Trevena Inc revolves around developing and commercializing innovative therapies for patients suffering from central nervous system (CNS) disorders. The company focuses on identifying and targeting G protein-coupled receptors (GPCRs) to develop new drugs. Trevena Inc utilizes its proprietary drug discovery platform to design and develop differentiated candidates that have the potential to address significant unmet medical needs. Through strategic collaborations and licensing agreements, Trevena Inc aims to maximize the reach and impact of its novel therapies, ultimately improving patient outcomes and creating value for its shareholders.

What is the P/E ratio of Trevena 2024?

The Trevena P/E ratio is -0.09.

What is the P/S ratio of Trevena 2024?

The Trevena P/S ratio is 14.37.

What is the Quality Investing of Trevena?

The Quality Investing for Trevena is 5/10.

What is the revenue of Trevena 2024?

The expected Trevena revenue is 163,200 USD.

How high is the profit of Trevena 2024?

The expected Trevena profit is -27.04 M USD.

What is the business model of Trevena

Trevena Inc is an innovative biotechnology company that aims to revolutionize the treatment of severe diseases. The company's business model is based on the research, development, and marketing of drugs that target a new class of G protein-coupled receptors to optimize the effects of medications. Trevena focuses on developing new and innovative therapeutics to combat severe diseases such as pain, respiratory, and cardiovascular diseases. The company develops drugs that can alleviate the symptoms of these diseases and significantly improve patients' quality of life. One product currently in the final phase of clinical trials is Oliceridine injection (marketed as "Olinvo"), a treatment for acute pain that can occur in patients during and after surgery. Trevena's added value lies in discovering and selecting novel G protein-coupled receptors that have proven to be uniquely effective. The company has the ability to identify innovative drug candidates with high potency and improved safety and tolerability profiles. Through their proprietary platform and expertise in preclinical and clinical research, Trevena can efficiently and rapidly develop innovative drugs. The company operates on a three-stage business model. The first phase involves the discovery and selection of drug candidates, which are then tested for efficacy and tolerability in preclinical studies. In the second phase, the company conducts clinical trials, testing the drugs on healthy subjects and later on patients with specific diseases. The final phase is the approval and commercialization of drugs that successfully pass the clinical trials and receive approval from regulatory authorities. Trevena has an extensive pipeline of drug candidates at various stages of development. In addition to Oliceridine injection, the company is developing TRV250 (marketed as "Pullevin"), a drug for the treatment of migraine attacks and dizziness caused by overactivation of specific G protein-coupled receptors. Also in Trevena's pipeline is TRV734, a pain medication that targets the effects of opioid medications, which have a high potential for dependence. Overall, Trevena has a solid business model with the potential to bring innovative and much-needed medications to the market. With its proprietary platform and expertise in preclinical and clinical research, the company aims to elevate the treatment of severe diseases to a new level.

What is the Trevena dividend?

Trevena pays a dividend of 0 USD distributed over payouts per year.

How often does Trevena pay dividends?

The dividend cannot currently be calculated for Trevena or the company does not pay out a dividend.

What is the Trevena ISIN?

The ISIN of Trevena is US89532E1091.

What is the Trevena WKN?

The WKN of Trevena is A1XDSL.

What is the Trevena ticker?

The ticker of Trevena is TRVN.

How much dividend does Trevena pay?

Over the past 12 months, Trevena paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Trevena is expected to pay a dividend of 0 USD.

What is the dividend yield of Trevena?

The current dividend yield of Trevena is .

When does Trevena pay dividends?

Trevena pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Trevena?

Trevena paid dividends every year for the past 0 years.

What is the dividend of Trevena?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Trevena located?

Trevena is assigned to the 'Health' sector.

Wann musste ich die Aktien von Trevena kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Trevena from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did Trevena pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of Trevena in the year 2023?

In the year 2023, Trevena distributed 0 USD as dividends.

In which currency does Trevena pay out the dividend?

The dividends of Trevena are distributed in USD.

All fundamentals about Trevena

Our stock analysis for Trevena Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trevena Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.